Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492583 · ClinicalTrials.gov registry record · Phase 3
Study to Investigate the Potential of Probiotics in Yogurt
A Phase 3 study of Healthy, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 182
- Enrollment target
- 1
- Study location
NCT00492583 is a Phase 3 study of Healthy that has completed, run by Georgetown University. The registered enrollment target is 182 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00492583, a Phase 3 study of Healthy, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the consumption of a yogurt drink containing a high dose of probiotics decreases absences, due to illnesses, in daycare centers for children between the ages of 1 and 3.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Bifidobacterium lactis (BB-12)
Study Locations (1)
District of Columbia
- Georgetown University Department of Family Medicine - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00492583
The ClinicalTrials.gov registry entry for NCT00492583 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00492583 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00492583 about?
NCT00492583 is a clinical study titled "Study to Investigate the Potential of Probiotics in Yogurt". The purpose of this study is to determine if the consumption of a yogurt drink containing a high dose of probiotics decreases absences, due to illnesses, in daycare centers for children between the ages of 1 and 3.
What is the current status of trial NCT00492583?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 182 participants. The study started on 2007-07. Estimated completion is 2008-08.
What conditions does trial NCT00492583 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00492583?
The interventions under investigation include: Placebo (DRUG), Bifidobacterium lactis (BB-12) (DRUG).
Who is sponsoring clinical trial NCT00492583?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00492583 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
RECRUITING · Phase 3
-
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
RECRUITING · Phase 3
-
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
COMPLETED · Phase 3
-
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
COMPLETED · Phase 3
-
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants
COMPLETED · Phase 3
-
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.